ORASURE TECHNOLOGIES, INC

OSUR ·Healthcare, Medical Devices, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $-7.8M
Depreciation & Amortization $3.0M
Depreciation
Amortization
Stock-Based Compensation $3.9M
Net Cash from Operating Activities $-292.8K
Investing Activities
Capital Expenditures $1.2M
Business Acquisitions
Net Cash from Investing Activities $36.9M
Financing Activities
Dividends Paid
Stock Repurchases $700.2K
Net Cash from Financing Activities $-1.2M
Net Change in Cash $35.4M
Free Cash Flow $-1.5M
← Newer Page 3 of 3 Older →